+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Takeda Pharmaceutical Company Limited - logo

Takeda Pharmaceuticals is the largest pharmaceutical company in Asia and a top 15 pharmaceutical company in the world. It provides products in various therapeutic areas, including gastroenterology, oncology, central nervous system, cardiovascular and metabolic, vaccines, and others. Takeda was founded in 1781 and operates two primary bases in Japan in Osaka and Tokyo. Its global operations are based in Zurich, Switzerland.

Ovarian Cancer Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update - Product Thumbnail Image

Ovarian Cancer Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

  • Report
  • December 2022
  • 1560 Pages
  • Global
From
The Corporate Reputation of Pharma in 2021- The Patient Perspective - Autoimmune Edition - The Views of 293 Patient Groups (138 of these respondent patient groups specialised in arthritis) - Product Thumbnail Image

The Corporate Reputation of Pharma in 2021- The Patient Perspective - Autoimmune Edition - The Views of 293 Patient Groups (138 of these respondent patient groups specialised in arthritis)

  • Report
  • November 2022
  • 57 Pages
  • Global
The Corporate Reputation of Pharma in 2022 - The Patient Perspective - Neurology Edition: The Views of 258 Neurology Patient Groups - Product Thumbnail Image

The Corporate Reputation of Pharma in 2022 - The Patient Perspective - Neurology Edition: The Views of 258 Neurology Patient Groups

  • Report
  • November 2022
  • 54 Pages
  • Global
Friedreich Ataxia - Global Clinical Trials Review, 2025 - Product Thumbnail Image

Friedreich Ataxia - Global Clinical Trials Review, 2025

  • Clinical Trials
  • January 2025
  • 108 Pages
  • Global
From
The Corporate Reputation of Pharma in 2021 - The Patient Perspective - Spain Edition: The Views of 154 Spanish Patient Groups - Product Thumbnail Image

The Corporate Reputation of Pharma in 2021 - The Patient Perspective - Spain Edition: The Views of 154 Spanish Patient Groups

  • Report
  • September 2022
  • 559 Pages
  • Spain
The Corporate Reputation of Pharma in 2021 - The Patient Perspective - Italy Edition: The Views of 103 Italian Patient Groups - Product Thumbnail Image

The Corporate Reputation of Pharma in 2021 - The Patient Perspective - Italy Edition: The Views of 103 Italian Patient Groups

  • Report
  • September 2022
  • 59 Pages
  • Italy
Schizophrenia Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update - Product Thumbnail Image

Schizophrenia Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

  • Report
  • September 2022
  • 295 Pages
  • Global
From
Melanin Concentrating Hormone Receptor Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Application, Product Type - Product Thumbnail Image

Melanin Concentrating Hormone Receptor Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Application, Product Type

  • Report
  • October 2024
  • 74 Pages
  • Global
From
20s Proteasome Inhibitor - Pipeline Insight, 2024 - Product Thumbnail Image

20s Proteasome Inhibitor - Pipeline Insight, 2024

  • Clinical Trials
  • January 2024
  • 90 Pages
  • Global
From
CCR2 Inhibitor - Pipeline Insight, 2024 - Product Thumbnail Image

CCR2 Inhibitor - Pipeline Insight, 2024

  • Clinical Trials
  • January 2024
  • 90 Pages
  • Global
From
Aurora Kinase Inhibitor - Pipeline Insight, 2024 - Product Thumbnail Image

Aurora Kinase Inhibitor - Pipeline Insight, 2024

  • Clinical Trials
  • January 2024
  • 60 Pages
  • Global
From
Thyroid Gland Disorders Treatment Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive Strategies and Forecasts, 2021 to 2029 - Product Thumbnail Image

Thyroid Gland Disorders Treatment Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive Strategies and Forecasts, 2021 to 2029

  • Report
  • September 2021
  • 99 Pages
  • Global
From
The Corporate Reputation of Pharma in 2021- The Patient Perspective - Germany Edition - The Views of 151 German Patient Groups - Product Thumbnail Image

The Corporate Reputation of Pharma in 2021- The Patient Perspective - Germany Edition - The Views of 151 German Patient Groups

  • Report
  • August 2022
  • 59 Pages
  • Germany
The Corporate Reputation of Pharma in 2021 - The Patient Perspective - Asia Edition - The Views of 300 Asian Patient Groups - Product Thumbnail Image

The Corporate Reputation of Pharma in 2021 - The Patient Perspective - Asia Edition - The Views of 300 Asian Patient Groups

  • Report
  • August 2022
  • 58 Pages
  • Asia Pacific
Immunology Drug Global Market Insights 2024, Analysis and Forecast to 2029, by Market Participants, Regions, Technology, Application, Product Type - Product Thumbnail Image

Immunology Drug Global Market Insights 2024, Analysis and Forecast to 2029, by Market Participants, Regions, Technology, Application, Product Type

  • Report
  • February 2024
  • 100 Pages
  • Global
From
Autoimmune Drug Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Application - Product Thumbnail Image

Autoimmune Drug Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Application

  • Report
  • February 2024
  • 141 Pages
  • Global
From
BRAFV600 mutation (B-Raf proto-oncogene, serine/threonine kinase) Inhibiotors - Pipeline Insight, 2024 - Product Thumbnail Image

BRAFV600 mutation (B-Raf proto-oncogene, serine/threonine kinase) Inhibiotors - Pipeline Insight, 2024

  • Clinical Trials
  • January 2024
  • 90 Pages
  • Global
From
Proteasome inhibitors - Pipeline Insight, 2024 - Product Thumbnail Image

Proteasome inhibitors - Pipeline Insight, 2024

  • Clinical Trials
  • January 2024
  • 60 Pages
  • Global
From
Antidiabetic SGLT-2 Inhibitor Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Application, Product Type - Product Thumbnail Image

Antidiabetic SGLT-2 Inhibitor Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Application, Product Type

  • Report
  • September 2024
  • 96 Pages
  • Global
From
Aurora-A kinase inhibitors - Pipeline Insight, 2024 - Product Thumbnail Image

Aurora-A kinase inhibitors - Pipeline Insight, 2024

  • Clinical Trials
  • January 2024
  • 60 Pages
  • Global
From
Loading Indicator